Skip to main content

Table 2 Correlation between variations in body composition and psychiatric symptoms after intragastric balloon (IGB) treatment (∆ for all variables)

From: Impact of a 6-month treatment with intragastric balloon on body composition and psychopathological profile in obese individuals with metabolic syndrome

 

BMI (kg/m2)

Weight (kg)

Waist (cm)

Total fat (g)

Total fat (%)

Lean mass (g)

BDI

r = 0.11

p = 0.48

r = 0.12

p = 0.46

r = 0.24

p = 0.14

r = 0.20

p = 0.26

r = 0.46

p = 0.008

r = −0.04

p = 0.81

HADS-depression

r = 0.02

p = 0.87

r = 0.05

p = 0.75

r = 0.23

p = 0.16

r = −0.02

p = 0.89

r = 0.12

p = 0.50

r = 0.05

p = 0.77

HADS-anxiety

r = 0.27

p = 0.084

r = 0.28

p = 0.08

r = 0.38

p = 0.017

r = 0.21

p = 0.22

r = 0.42

p = 0.014

r = 0.22

p = 0.21

  1. DXA dual-energy X-ray absorptiometry; BMI body mass index; BDI Beck Depression Inventory; HADS hospital anxiety and depression scale; HADS-D hospital anxiety and depression scale-depression; HADS-A hospital anxiety and depression scale-anxiety